Int J Angiol 2007; 16(4): 121-127
DOI: 10.1055/s-0031-1278264
Review

© Georg Thieme Verlag KG Stuttgart · New York

Management of small asymptomatic abdominal aortic aneurysms - a review

H. Silaghi1 , A. Branchereau2 , S. Malikov2 , Aurel Andercou1
  • 1Surgical Clinic II, UMPh Cluj-Napoca, Cluj-Napoca, Romania;
  • 2Service de Chirurgie Vasculaire, Hôpital de la Timone, Université de la Méditerranée, Marseille, France
Further Information

Publication History

Publication Date:
27 April 2011 (online)

Abstract

H Silaghi, A Branchereau, S Malikov, A Andercou. Management of small asymptomatic abdominal aortic aneurysms - a review. Int J Angiol 2007;16(4):121-127.

The approach for abdominal aortic aneurysms (AAAs) larger than 55 mm is well defined due to the risk of rupture being higher than 10% per year, and a 30-day perioperative mortality rate between 2.5% and 5%. However, the approach for small asymptomatic AAAs is less well defined.

There are different definitions given to describe a small AAA. The one the authors accepted and applied is “a localized, permanent and irreversible dilation of the aorta of at least 50% in relation to the normal adjacent infrarenal or suprarenal aorta, with a maximum diameter between 30-55 mm".

The investigators of the largest study on small AAAs (United Kingdom Small Aneurysm Trial [UK-SAT]) concluded, in brief, that ultrasound monitoring is the most appropriate solution because the results do not support a policy of surgical restoration for AAAs with a diameter of between 40 mm and 55 mm.

The aim of the present review article is to highlight several challenges that could change the limits or create a more flexible deciding factor in the management of AAAs. There are multiple factors that influence surgical decision-making, and the limit on aneurysm diameter that indicates surgery should depend on the patient's age, life expectancy, general status, associated diseases, diameter in relation to body mass, risk factors, sex, anxiety and compliance during the follow-up period. Monitoring is an acceptable alternative for AAAs between 40 mm and 55 mm, and is probably the best solution for high-risk patients. Surgery is the most reasonable solution for patients who are at moderate risk, have a significant life expectancy, are less than 70 to 75 years of age, and/or have aortic aneurysms larger than 50 mm.

    >